María Jesus Salido Rojo
Startup Contributor
María Jesús Salido Rojo
CEO
Social Diabetes
https://linkedin.com/in/mariasalido
https://twitter.com/socialdiabetes
https://www.socialdiabetes.com/
There will be a ‘before’ and ‘after’ of the pandemic crisis and it is easy to imagine that the new world will force a rethink of the rules of the game
Fernando Becerril Orta
Expert Contributor
Fernando Becerril Orta
Senior Partner
Becerril, Coca & Becerril
https://www.linkedin.com/in/fernando-becerril-72234521
https://twitter.com/BCB_IP
https://www.bcb.com.mx/
From marijuana to medication procurement, there are many pending issues that need to be clarified from a regulatory point of view.
Raymundo Ceja
View from the Top
Raymundo Ceja
President
IT Cluster of Zacatecas
Zacatecas is primarily known for its strong mining industry. Can it become a significant player in technology innovation?
Health
News Article
In the most recent WTO report, Mexico was ranked fifth among the main exporters of critical medical products to combat COVID-19 in 2020.
Michel Yehuda, Dominion
View from the Top
Michel Yehuda
Industrial Business Unit Director
DOMINION
Michel Yehuda discusses the company’s technological expertise in various sectors, including support for CFE’s transmission and distribution.
Philippe Fournet-Fayard
Expert Contributor
Philippe Fournet-Fayard
CEO
Eolis
https://www.linkedin.com/in/philippe-fournet-fayard-8227685/?originalSubdomain=mx
http://eolis.com.mx/
Industries that invest for a long period of time in operations gain a huge benefit by focusing on total cost, including purchasing and operation.
Agustin Azcatl Romero
Expert Contributor
Agustin Azcatl Romero
Patents Division Partner
Ortiz & Ramírez Abogados
https://www.linkedin.com/in/agustin-azcatl-4286862/
http://www.gelo.com.mx
IMPI provides a new dynamic for the pharma industry with the expectation that industrial property is used as a tool for growth and not as a barrier.
Rafael Gual
Expert Contributor
Rafael Gual
Director General
National Chamber of the Pharmaceutical Industry CANIFARMA
What do changes to the regulatory framework represent, and what consequences can be expected?
Jorge Camargo
Expert Contributor
Jorge Camargo
President
Ecaresoft
https://www.ecaresoft.com/es-mx/
Annual economic loss due to depression and anxiety is almost US$1 trillion but investing on treatment generates a return of $5 for every dollar spent
Subscribe to health